Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Innovation
Share your love
Q&A: As DMEI turns 50, R. Michael Siatkowski, MD, MBA, looks to the future | Ophthalmology Times
R. Michael Siatkowski, MD, MBA, reflects on 50 years of innovation, research, and patient care at the Dean McGee Eye Institute and shares his vision for the future of ophthalmology. (Courtesy of Dean McGee Eye Institute) As Dean McGee Eye…
AAO 2025 Takeaways: Cornea, refractive surgery, and aesthetics redefined | Ophthalmology Times
(Image Credit: AdobeStock/Pixel-Shot) Editor’s Note: This content was generated with the assistance of AI. AAO 2025 delivered major insights into anterior segment innovation, spanning corneal cross-linking care, refractive surgery evolution, and energy-based aesthetic technology. Presentations from Reena Gupta, MD; Arjan…
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision | Ophthalmology Times
(Image Credit: AdobeStock/andrew_shots) Editor’s Note: This content was generated with the assistance of AI. AAO 2025 showcased a powerful convergence of innovation in glaucoma care, emphasizing safer long-term pressure control, improved visualization technologies, and more individualized lens decision-making for complex…
AAO 2025: The value of RGB imaging in OCT | Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, a professor of ophthalmology at UCLA and the Doheny Eye Institute, discussed advancements in ophthalmological imaging technology, specifically focusing on the Silverstone platform with RGB imaging capabilities. The key innovation of this platform is the…
From lab to clinic: Advancing ophthalmic technology | Ophthalmology Times
Emerging diagnostic and surgical technologies are enhancing precision, improving efficiency, and shaping the future of patient care in ophthalmology. (Image credit: AdobeStock/Olivier Le Moal) As ophthalmic technology continues to advance, new diagnostic and surgical devices are redefining precision, efficiency, and…
Eli Lilly to acquire Adverum Biotechnologies | Ophthalmology Times
Image credit: AdobeStock/jozefmicic The Eli Lilly and Company will acquire Adverum Biotechnologies, according to a joint press release issued by the 2 companies. The companies noted that this definitive agreement will include Adverum’s lead candidate, Ixo-vec. Adverum and Lilly’s merger…
Throwback Series: From epidemic to innovation in corneal surgery | Ophthalmology Times
In celebration of Ophthalmology Times’ 50th anniversary, leaders revisit a memorable “throwback” case from earlier in their careers. In this special series, they reflect on how evolving knowledge, techniques, and technologies have transformed the way such cases are managed today.…
Cataract and refractive surgery: Trends, challenges, and innovations | Ophthalmology Times
Ongoing innovation in cataract and refractive surgery is driving improved precision, safety, and patient outcomes. (Image credit: AdobeStock/Seventyfour) Cataract and refractive surgery continues to evolve at a rapid pace, driven by advances in intraocular lenses (IOLs), laser technology, and surgical…
The future of glaucoma care: Where innovation meets everyday practice | Ophthalmology Times
Specialists in glaucoma care share insights on evolving strategies, technologies, and treatments shaping the future of patient management. (Image credit: AdobeStock) As glaucoma care continues to advance, ophthalmologists are embracing innovative technologies and new approaches that are reshaping diagnosis and…
From numbers to meaning: Graphical reporting in refractive surgery | Ophthalmology Times
(Image Credit: AdobeStock/lucadp) In the rapidly evolving field of refractive surgery, the gap between surgical innovation and outcomes analysis has long hindered clinical progress. Without standardized methods to measure and compare surgical outcomes, clinicians struggled to identify which techniques truly…